Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1996 May;74(5):400–405. doi: 10.1136/adc.74.5.400

The changing clinical pattern of Reye's syndrome 1982-1990.

R M Hardie 1, L H Newton 1, J C Bruce 1, J F Glasgow 1, A P Mowat 1, J B Stephenson 1, S M Hall 1
PMCID: PMC1511546  PMID: 8669954

Abstract

OBJECTIVE: To describe trends in the clinical pattern of Reye's syndrome in the British Isles between 1982 and 1990; and to determine the relation between any changes and the June 1986 warnings against the use of aspirin in children. DESIGN: Development, and application to reported cases, of a scoring system designed such that patients showing the typical clinical and pathological features of 'classical' Reye's syndrome scored highly. The relations between 'Reye scores' and a number of explanatory variables were explored using multivariable analysis. SETTING: British Isles. SUBJECTS: 445 cases fulfilling the Reye's syndrome case definition reported to the surveillance scheme between January 1982 and December 1990. MAIN OUTCOME MEASURE: Individual 'Reye score'. RESULTS: Cases with high scores were more likely to have occurred in the 4 1/2 year period before June 1986 compared with the subsequent period (p < 0.006). Numbers of cases in the low and intermediate score categories declined by about 50% after June 1986, whereas those in the high category fell by 79%. High scorers were more likely to have received aspirin (p < 0.0001) and were older than intermediate and low scorers (p < 0.008). No relation was identified between score and season of onset. CONCLUSIONS: The decline in Reye's syndrome after the aspirin warnings cannot be explained entirely, as has been proposed, by improved diagnosis of 'Reye-like' inherited metabolic and other disorders: this would not account for the greater decline of the high scoring subgroup which also contained those cases most likely to resemble 'classical' Reye's syndrome and to have received aspirin. This study provides further evidence for the role of aspirin in a subset of cases meeting the standard diagnostic criteria for Reye's syndrome and supports the need to consider this disorder as a heterogeneous group of conditions including Reye-like inherited metabolic disorders.

Full text

PDF
400

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Casteels-Van Daele M. Reduction of deaths after drug labelling for risk of Reye's syndrome. Lancet. 1993 Jan 9;341(8837):118–119. doi: 10.1016/0140-6736(93)92599-o. [DOI] [PubMed] [Google Scholar]
  2. Casteels-van Daele M., Eggermont E. Reye's syndrome. BMJ. 1994 Apr 2;308(6933):919–920. doi: 10.1136/bmj.308.6933.919b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Daniels S. R., Greenberg R. S., Ibrahim M. A. Scientific uncertainties in the studies of salicylate use and Reye's syndrome. JAMA. 1983 Mar 11;249(10):1311–1316. [PubMed] [Google Scholar]
  4. Faraj B. A., Caplan D., Lolies P., Buchanan C. Salicylate and mitochondrial monoamine oxidase function in Reye's syndrome. J Pharm Sci. 1987 Jun;76(6):423–426. doi: 10.1002/jps.2600760602. [DOI] [PubMed] [Google Scholar]
  5. Forsyth B. W., Horwitz R. I., Acampora D., Shapiro E. D., Viscoli C. M., Feinstein A. R., Henner R., Holabird N. B., Jones B. A., Karabelas A. D. New epidemiologic evidence confirming that bias does not explain the aspirin/Reye's syndrome association. JAMA. 1989 May 5;261(17):2517–2524. [PubMed] [Google Scholar]
  6. Forsyth B. W., Shapiro E. D., Horwitz R. I., Viscoli C. M., Acampora D. Misdiagnosis of Reye's-like illness. Am J Dis Child. 1991 Sep;145(9):964–966. doi: 10.1001/archpedi.1991.02160090014005. [DOI] [PubMed] [Google Scholar]
  7. Gauthier M., Guay J., Lacroix J., Lortie A. Reye's syndrome. A reappraisal of diagnosis in 49 presumptive cases. Am J Dis Child. 1989 Oct;143(10):1181–1185. [PubMed] [Google Scholar]
  8. Glasgow J. F., Moore R. Reye's syndrome 30 years on. BMJ. 1993 Oct 16;307(6910):950–951. doi: 10.1136/bmj.307.6910.950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Green A., Hall S. M. Investigation of metabolic disorders resembling Reye's syndrome. Arch Dis Child. 1992 Oct;67(10):1313–1317. doi: 10.1136/adc.67.10.1313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hall S. M., Plaster P. A., Glasgow J. F., Hancock P. Preadmission antipyretics in Reye's syndrome. Arch Dis Child. 1988 Jul;63(7):857–866. doi: 10.1136/adc.63.7.857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Halpin T. J., Holtzhauer F. J., Campbell R. J., Hall L. J., Correa-Villaseñor A., Lanese R., Rice J., Hurwitz E. S. Reye's syndrome and medication use. JAMA. 1982 Aug 13;248(6):687–691. [PubMed] [Google Scholar]
  12. Hurwitz E. S., Barrett M. J., Bregman D., Gunn W. J., Pinsky P., Schonberger L. B., Drage J. S., Kaslow R. A., Burlington D. B., Quinnan G. V. Public Health Service study of Reye's syndrome and medications. Report of the main study. JAMA. 1987 Apr 10;257(14):1905–1911. [PubMed] [Google Scholar]
  13. Hurwitz E. S., Barrett M. J., Bregman D., Gunn W. J., Schonberger L. B., Fairweather W. R., Drage J. S., LaMontagne J. R., Kaslow R. A., Burlington D. B. Public Health Service study on Reye's syndrome and medications. Report of the pilot phase. N Engl J Med. 1985 Oct 3;313(14):849–857. doi: 10.1056/NEJM198510033131403. [DOI] [PubMed] [Google Scholar]
  14. Hurwitz E. S. Reye's syndrome. Epidemiol Rev. 1989;11:249–253. doi: 10.1093/oxfordjournals.epirev.a036043. [DOI] [PubMed] [Google Scholar]
  15. Hurwitz E. S. The changing epidemiology of Reye's syndrome in the United States: further evidence for a public health success. JAMA. 1988 Dec 2;260(21):3178–3180. doi: 10.1001/jama.1988.03410210090045. [DOI] [PubMed] [Google Scholar]
  16. Khan A. S., Kent J., Schonberger L. B. Aspirin and Reye's syndrome. Lancet. 1993 Apr 10;341(8850):968–968. doi: 10.1016/0140-6736(93)91266-o. [DOI] [PubMed] [Google Scholar]
  17. Martens M. E., Lee C. P. Reye's syndrome: salicylates and mitochondrial functions. Biochem Pharmacol. 1984 Sep 15;33(18):2869–2876. doi: 10.1016/0006-2952(84)90209-0. [DOI] [PubMed] [Google Scholar]
  18. Orlowski J. P., Campbell P., Goldstein S. Reye's syndrome: a case control study of medication use and associated viruses in Australia. Cleve Clin J Med. 1990 Jun;57(4):323–329. doi: 10.3949/ccjm.57.4.323. [DOI] [PubMed] [Google Scholar]
  19. Orlowski J. P., Gillis J., Kilham H. A. A catch in the Reye. Pediatrics. 1987 Nov;80(5):638–642. [PubMed] [Google Scholar]
  20. Partin J. S., Daugherty C. C., McAdams A. J., Partin J. C., Schubert W. K. A comparison of liver ultrastructure in salicylate intoxication and Reye's syndrome. Hepatology. 1984 Jul-Aug;4(4):687–690. doi: 10.1002/hep.1840040421. [DOI] [PubMed] [Google Scholar]
  21. Rowe P. C., Valle D., Brusilow S. W. Inborn errors of metabolism in children referred with Reye's syndrome. A changing pattern. JAMA. 1988 Dec 2;260(21):3167–3170. [PubMed] [Google Scholar]
  22. Starko K. M., Ray C. G., Dominguez L. B., Stromberg W. L., Woodall D. F. Reye's syndrome and salicylate use. Pediatrics. 1980 Dec;66(6):859–864. [PubMed] [Google Scholar]
  23. Trauner D. A., Horvath E., Davis L. E. Inhibition of fatty acid beta oxidation by influenza B virus and salicylic acid in mice: implications for Reye's syndrome. Neurology. 1988 Feb;38(2):239–241. doi: 10.1212/wnl.38.2.239. [DOI] [PubMed] [Google Scholar]
  24. Waldman R. J., Hall W. N., McGee H., Van Amburg G. Aspirin as a risk factor in Reye's syndrome. JAMA. 1982 Jun 11;247(22):3089–3094. [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES